Recent advances in site-selective transformations of β-enaminones via transition-metal-catalyzed C–H functionalization/annulation
Organic & Biomolecular Chemistry · 2025 · 23 (1) · 36-58
DOI: 10.1039/d4ob01612b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Organic & Biomolecular Chemistry, 2025. Verfasst von Prasanta Roy und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea. leesw1212@ynu.ac.kr. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 137 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
β-Enaminone transformation strategies are widely employed in the synthesis of numerous biologically active drugs and natural products, highlighting their significance in medicinal chemistry.
Autor:innen und Institutionen
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea. leesw1212@ynu.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Roy, P., Mahato, K., Shrestha, D., Mohandoss, S., Lee, S. W., & Lee, Y. R. (2025). Recent advances in site-selective transformations of β-enaminones via transition-metal-catalyzed C–H functionalization/annulation. Organic & Biomolecular Chemistry, 23(1), 36-58. https://doi.org/10.1039/d4ob01612b
Vancouver
Roy P, Mahato K, Shrestha D, Mohandoss S, Lee SW, Lee YR. Recent advances in site-selective transformations of β-enaminones via transition-metal-catalyzed C–H functionalization/annulation. Organic & Biomolecular Chemistry. 2025;23(1):36-58. doi:10.1039/d4ob01612b
BibTeX
@article{Roy2025,
author = {Roy, Prasanta and Mahato, Karuna and Shrestha, Divya and Mohandoss, Sonaimuthu and Lee, Seung Woo and Lee, Yong Rok},
title = {Recent advances in site-selective transformations of β-enaminones via transition-metal-catalyzed C–H functionalization/annulation},
journal = {Organic & Biomolecular Chemistry},
year = {2025},
volume = {23},
number = {1},
pages = {36--58},
doi = {10.1039/d4ob01612b}
}
EUVIMED